Senior Director, Global Scientific Communications
Annexon BiosciencesBrisbane, California, United States · Posted 2 days agoDescription
Company:
At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.
For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.
We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture!
Position:
Senior Director, Global Scientific Communications, will be a strategic partner responsible for developing, managing, and executing Annexon’s global scientific communications strategy and content across various platforms to support the companies’ medical and scientific objectives. This role involves creating high-quality publications and scientific materials, managing communication processes, leading the Medical Information function and ensuring compliance with regulations and best practices. This position will work closely with internal teams and external stakeholders to advance the scientific narrative and impact of Annexon’s therapeutic areas. This role will report to the Sr. Vice President of Global Medical Affairs.
Responsibilities include:
- Develop and execute an integrated global strategy for Scientific Communications, Publications, and Medical Information aligned with corporate and therapeutic area Medical Affairs objectives; delivering measurable impact across internal and external stakeholders
- In collaboration with internal partners and utilizing externally derived insights, develop robust global scientific communications and publication strategies across Annexon’s therapeutic areas.
- Direct the creation of high-quality scientific communications (inclusive of scientific platforms, lexicons, abstracts, manuscripts, congress presentations, publications) and related processes.
- Develop scientific content for non-CME presentations at medical conferences, advisory board meetings, congress exhibits, field medical presentations, and internal Annexon meetings.
- Develop and lead Medical Information strategy and operations; accountable all aspects of Medical Information, including but limited to creation of procedures and norms, oversight of staff and vendors, and creation of materials used to respond to unsolicited medical requests responses from external parties including but not limited to health care professionals, patients, and health care organizations.
- Establish and implement a process for tracking all scientific communications across Annexon to ensure timely, and compliant execution of Annexon’s scientific/medical communication plan.
- Collaborate with internal stakeholders in Program Strategy & Operations, and all functional areas to ensure real-time knowledge, and on-time execution of data communications, including but not limited to congress abstract submissions, publications, and external Annexon presentations.
- Drive innovation in scientific engagement utilizing emerging technologies to implement omnichannel medical education approaches.
- Manage all scientific communication plan timelines and KPIs; communicate progress regularly with all internal and external stakeholders.
- Serve as a senior strategic partner to therapeutic area Medical Affairs Leads, field medial leadership, clinical development and project leadership to establish and implement effective scientific communications strategies and deliverables.
- Represent Annexon with external stakeholders such as authors, journals, scientific/medical societies, and other relevant third parties.
- Lead the identification of and engagement with Annexon’s publication and medical education vendor(s).
- Maintain cutting edge knowledge of all regulations and best practices for scientific communication, publications, Medical Information and education.
Education, Experience, and Skills:
Required:
- Advanced degree (PharmD, MD, PhD) required
- Significant experience (minimum of 10 years) and leadership in Scientific Communications, Publication and/or Medical Affairs
- Therapeutic area expertise in neurology, and/or ophthalmology preferred
- Proven partner management skills to achieve results based on key performance indicators.
- Thorough knowledge of pharmaceutical product development, product lifecycle, and commercialization process
- Knowledge of GPP, ICMJE and all applicable regional, and international regulations and guidelines
- Project management, and resource planning/management experience
- Skilled at effectively communicating complex scientific/clinical concepts and data in written and oral forms.
- Experienced at engagement and scientific exchange with scientists and clinicians.
- Proven record of solving problems coupled with exhibiting good judgement regarding relevant issues
Salary Range: 290,000 - 320,000 USD
Location: Annexon Biosciences is located in Brisbane, California and preference is given to candidates in the San Francisco Bay Area.
Benefits:
- A stimulating and rewarding workplace includes flexible work schedules, remote opportunities and the ability to achieve a work-life balance.
- Shuttle service from BART, CalTrain and the Ferry.
- Annexon offers a competitive base salary and equity participation, employee stock purchase plan, as well as a comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, and other benefits.
Annexon Biosciences is an Equal Opportunity Employer, and we prohibit discrimination or harassment of any kind. We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths, views, and experiences. We believe that our differences enable us to be a better team – one that makes better decisions, drives innovation, and delivers better business results. Creativity and innovation flourish in an environment of openness, inclusion, and mutual respect.
Similar jobs
Est. 271,500 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 365,650 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 275,000 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 365,600 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 337,500 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 325,000 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 355,000 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 315,750 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 207,000 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 413,550 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 189,500 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 205,950 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 232,500 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 167,600 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 170,000 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 248,800 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 270,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 221,450 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 86,104 USD
Axogen is committed to building and maintaining a strong and gratifying company culture that fosters professional growth. Our hands-on and personal approach makes transitioning to a new job a seamless and enjoyable proce…
Est. 232,500 USD
Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. The Company is headquartered in London, UK, with a…
Est. 120,000 USD
About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Sum…
Est. 237,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 317,500 USD
Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic condition…
Est. 204,800 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…
Est. 176,750 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…
Est. 140,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 160,350 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 273,800 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 220,450 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…
Est. 246,850 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…